Online Database of Chemicals from Around the World
2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine
[CAS# 186043-52-7]
Complete supplier list of 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine
|
Identification
| Name |
2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine |
|---|
|
| Molecular Structure |
![CAS # 186043-52-7, 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine](/structures/186043-52-7.gif) |
| Molecular Formula |
C48H12F90N3O6P3 |
| Molecular Weight |
2529.40 |
| CAS Registry Number |
186043-52-7 |
| EC Number |
814-620-1 |
|
Properties
| Density |
1.85±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
|---|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
|
|
Safety Data
|
Hazard Classification |
|
|---|
| Hazard | Class | Category Code | Hazard Statement |
|---|
| Specific target organ toxicity - single exposure | STOT SE | 3 | H335 | | Eye irritation | Eye Irrit. | 2 | H319 | | Skin irritation | Skin Irrit. | 2 | H315 | |
|
|
SDS |
Available |
|
| Market Analysis Reports |
|
List of Reports Available for 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine
|
|
Related Products
rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide [3S-[2(R*),3alpha,8abeta]]-[2-[Hexahydro-1,4-dioxo-3-(phenylmethyl)pyrrolo[1,2-a]pyrazin-2(1H)-yl]-1-methyl-2-oxoethyl]carbamic acid phenylmethyl ester (S)-Hexahydro-2,6-dioxo-4-pyrimidinecarboxylic acid phenylmethyl ester 1,2,5,6,7,8-Hexahydro-2,5-dioxo-3-quinolinecarboxylic acid methyl ester Hexahydro-5,8-dioxo-3H-thiazolo[3,4-a]pyrazine-6-propanoic acid [2R-(2alpha,4abeta,5aalpha,8alpha,9aalpha,9bbeta)]-Hexahydro-2,8-diphenyl-4H-bis[1,3]dioxino[5,4-b:4',5'-d]pyrrole Hexahydro-4,8-ethano-1H,3H-benzo[1,2-c:4,5-c']difuran-1,3,5,7-tetrone (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol rel-(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl 4-nitrophenyl carbonic acid ester Hexahydro-1H-furo[3,4-c]pyrrole hydrochloride 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis((2,2,3,3,4,4,5,5,6,6,7,7,8,8-tetradecafluorooctyl)oxy)-1,3,5,2,4,6-triazatriphosphorine 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis(2,2,3,3-tetrafluoropropoxy)-1,3,5,2,4,6-triazatriphosphorine 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran 2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexaphenoxytriazatriphosphorine (4R)-Hexahydro-4-hydroxy-1H-azepine-1-carboxylic acid 1,1-dimethylethyl ester (4S)-Hexahydro-4-hydroxy-1H-azepine-1-carboxylic acid 1,1-dimethylethyl ester Hexahydro-4-hydroxy-1H-azepine-1-carboxylic acid phenylmethyl ester Hexahydro-5-hydroxy-1H-azepine-1,4-dicarboxylic acid 1-(tert-butyl) 4-ethyl ester (3aS,4S,6aR)-Hexahydro-N-[(3beta)-3-hydroxychol-5-en-24-yl]-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide Hexahydro-4-hydroxycyclopenta[c]pyrrole-2(1H)-carboxylic acid 1,1-dimethylethyl ester
